318 related articles for article (PubMed ID: 22780213)
21. Laboratory, morphologic, and immunophenotypic correlates of surface immunoglobulin heavy chain isotype expression in B-cell chronic lymphocytic leukemia.
Shen PU; Fuller SG; Rezuke WN; Sherburne BJ; DiGiuseppe JA
Am J Clin Pathol; 2001 Dec; 116(6):905-12. PubMed ID: 11764081
[TBL] [Abstract][Full Text] [Related]
22. B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage.
Dal-Bo M; Del Giudice I; Bomben R; Capello D; Bertoni F; Forconi F; Laurenti L; Rossi D; Zucchetto A; Pozzato G; Marasca R; Efremov DG; Guarini A; Del Poeta G; Foà R; Gaidano G; Gattei V
Br J Haematol; 2011 Apr; 153(1):3-14. PubMed ID: 21303354
[TBL] [Abstract][Full Text] [Related]
23. Management of chronic lymphocytic leukemia (CLL) in the era of B-cell receptor signal transduction inhibitors.
Mato A; Jauhari S; Schuster SJ
Am J Hematol; 2015 Jul; 90(7):657-64. PubMed ID: 25808792
[TBL] [Abstract][Full Text] [Related]
24. B-cell chronic lymphocytic leukemia, a clonal disease of B lymphocytes with receptors that vary in specificity for (auto)antigens.
Chiorazzi N; Hatzi K; Albesiano E
Ann N Y Acad Sci; 2005 Dec; 1062():1-12. PubMed ID: 16461783
[TBL] [Abstract][Full Text] [Related]
25. B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia.
Allsup DJ; Kamiguti AS; Lin K; Sherrington PD; Matrai Z; Slupsky JR; Cawley JC; Zuzel M
Cancer Res; 2005 Aug; 65(16):7328-37. PubMed ID: 16103084
[TBL] [Abstract][Full Text] [Related]
26. Immune thrombocytopenia in patients with chronic lymphocytic leukemia is associated with stereotyped B-cell receptors.
Visco C; Maura F; Tuana G; Agnelli L; Lionetti M; Fabris S; Novella E; Giaretta I; Reda G; Barcellini W; Baldini L; Neri A; Rodeghiero F; Cortelezzi A
Clin Cancer Res; 2012 Apr; 18(7):1870-8. PubMed ID: 22322667
[TBL] [Abstract][Full Text] [Related]
27. Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells.
Cutrona G; Colombo M; Matis S; Fabbi M; Spriano M; Callea V; Vigna E; Gentile M; Zupo S; Chiorazzi N; Morabito F; Ferrarini M
Haematologica; 2008 Mar; 93(3):413-22. PubMed ID: 18287138
[TBL] [Abstract][Full Text] [Related]
28. From normal to clonal B cells: Chronic lymphocytic leukemia (CLL) at the crossroad between neoplasia and autoimmunity.
Ghia P; Scielzo C; Frenquelli M; Muzio M; Caligaris-Cappio F
Autoimmun Rev; 2007 Dec; 7(2):127-31. PubMed ID: 18035322
[TBL] [Abstract][Full Text] [Related]
29. Aberrant B cell receptor signaling from B29 (Igbeta, CD79b) gene mutations of chronic lymphocytic leukemia B cells.
Gordon MS; Kato RM; Lansigan F; Thompson AA; Wall R; Rawlings DJ
Proc Natl Acad Sci U S A; 2000 May; 97(10):5504-9. PubMed ID: 10792036
[TBL] [Abstract][Full Text] [Related]
30. SLAMF receptors negatively regulate B cell receptor signaling in chronic lymphocytic leukemia via recruitment of prohibitin-2.
von Wenserski L; Schultheiß C; Bolz S; Schliffke S; Simnica D; Willscher E; Gerull H; Wolters-Eisfeld G; Riecken K; Fehse B; Altfeld M; Nollau P; Binder M
Leukemia; 2021 Apr; 35(4):1073-1086. PubMed ID: 32826957
[TBL] [Abstract][Full Text] [Related]
31. The meaning and relevance of B-cell receptor structure and function in chronic lymphocytic leukemia.
Stevenson FK; Forconi F; Packham G
Semin Hematol; 2014 Jul; 51(3):158-67. PubMed ID: 25048780
[TBL] [Abstract][Full Text] [Related]
32. Surface markers of lymphocytes and immunoglobulin alterations in chronic lymphocytic leukemia (CLL).
Aydar S; Oğüt A; Undük H; Gündüz M
New Istanbul Contrib Clin Sci; 1978 Mar; 12(2):152-60. PubMed ID: 16302701
[No Abstract] [Full Text] [Related]
33. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.
Rassenti LZ; Huynh L; Toy TL; Chen L; Keating MJ; Gribben JG; Neuberg DS; Flinn IW; Rai KR; Byrd JC; Kay NE; Greaves A; Weiss A; Kipps TJ
N Engl J Med; 2004 Aug; 351(9):893-901. PubMed ID: 15329427
[TBL] [Abstract][Full Text] [Related]
34. The origin of B-cell chronic lymphocytic leukemia.
Ghia P; Caligaris-Cappio F
Semin Oncol; 2006 Apr; 33(2):150-6. PubMed ID: 16616061
[TBL] [Abstract][Full Text] [Related]
35. Signal transduction inhibitors in chronic lymphocytic leukemia.
Ma S; Rosen ST
Curr Opin Oncol; 2011 Nov; 23(6):601-8. PubMed ID: 21892084
[TBL] [Abstract][Full Text] [Related]
36. [Cytoplasmic immunoglobulins in chronic B-lymphoid leukemia].
Filippi JF; Nicolino-Brunet C; Tubiana N; Carcassonne Y; Sampol J
Pathol Biol (Paris); 1991 Jan; 39(1):47-9. PubMed ID: 2011410
[TBL] [Abstract][Full Text] [Related]
37. B-cell receptor signaling in chronic lymphocytic leukemia.
Stevenson FK; Krysov S; Davies AJ; Steele AJ; Packham G
Blood; 2011 Oct; 118(16):4313-20. PubMed ID: 21816833
[TBL] [Abstract][Full Text] [Related]
38. B cell signalling pathways-New targets for precision medicine in chronic lymphocytic leukaemia.
Skånland SS; Karlsen L; Taskén K
Scand J Immunol; 2020 Nov; 92(5):e12931. PubMed ID: 32640099
[TBL] [Abstract][Full Text] [Related]
39. The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling.
Lorenzo-Herrero S; Sordo-Bahamonde C; Bretones G; Payer ÁR; González-Rodríguez AP; González-García E; Pérez-Escuredo J; Villa-Álvarez M; Núñez LE; Morís F; Gonzalez S; López-Soto A
Front Immunol; 2019; 10():2455. PubMed ID: 31681329
[TBL] [Abstract][Full Text] [Related]
40. Modeling the B-cell receptor signaling on single cell level reveals a stable network circuit topology between nonmalignant B cells and chronic lymphocytic leukemia cells and between untreated cells and cells treated with kinase inhibitors.
Wolf C; Maus C; Persicke MRO; Filarsky K; Tausch E; Schneider C; Döhner H; Stilgenbauer S; Lichter P; Höfer T; Mertens D
Int J Cancer; 2022 Sep; 151(5):783-796. PubMed ID: 35527719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
